Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 318, doi. 10.1038/cgt.2010.81
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2011 AND VI 18 AND IP 5
Results: 7
1
2
Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 370, doi. 10.1038/cgt.2011.13
- By:
- Publication type:
- Article
3
Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 336, doi. 10.1038/cgt.2010.83
- By:
- Publication type:
- Article
4
An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 326, doi. 10.1038/cgt.2010.82
- By:
- Publication type:
- Article
5
Evaluation and optimization of the administration of a selectively replicating herpes simplex viral vector to the brain by convection-enhanced delivery.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 358, doi. 10.1038/cgt.2011.2
- By:
- Publication type:
- Article
6
Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 346, doi. 10.1038/cgt.2010.84
- By:
- Publication type:
- Article
7
Clinical development directions in oncolytic viral therapy.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 5, p. 305, doi. 10.1038/cgt.2011.7
- By:
- Publication type:
- Article